Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Metagenomi Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get MGX alerts

About Matthew L. Wein

Matthew L. Wein is recorded as General Counsel at Metagenomi Therapeutics, Inc. (MGX). The newest filing on record that lists Matthew L. Wein as General Counsel at Metagenomi Therapeutics, Inc. (MGX) is dated April 27, 2026. The proxy statement of Metagenomi Therapeutics, Inc. reports total compensation of $756,384 for Matthew L. Wein in fiscal 2025, including a base salary of $407,151. Disclosed compensation is on record for 2 fiscal years. Metagenomi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Metagenomi Therapeutics, Inc. includes Jian Irish (CEO, COO and Board Member), Pamela Wapnick (CFO), Eric Bjerkholt (Board Member) and 5 others.

Affiliation history

Company network

Leadership on record at Metagenomi Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Metagenomi Therapeutics, Inc. (MGX) $407,151 $756,384
2024 Metagenomi Therapeutics, Inc. (MGX) — —

Recent activity

No call appearances or filed executive changes recorded yet.